VolitionRx Statistics

Total Valuation

VolitionRx has a market cap or net worth of $55.26 million. The enterprise value is $54.03 million.

Market Cap	55.26M
Enterprise Value	54.03M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

VolitionRx has 92.10 million shares outstanding. The number of shares has increased by 33.74% in one year.

Shares Outstanding	92.10M
Shares Change (YoY)	+33.74%
Shares Change (QoQ)	+0.87%
Owned by Insiders (%)	7.16%
Owned by Institutions (%)	9.13%
Float	72.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.52
Forward PS	10.64
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	55.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-121.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-100.82%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$8,877
Profits Per Employee	-$294,741
Employee Count	110
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.84% in the last 52 weeks. The beta is 1.10, so VolitionRx's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-25.84%
50-Day Moving Average	0.68
200-Day Moving Average	0.76
Relative Strength Index (RSI)	41.62
Average Volume (20 Days)	76,590

Short Selling Information

The latest short interest is 404,776, so 0.44% of the outstanding shares have been sold short.

Short Interest	404,776
Short Previous Month	399,091
Short % of Shares Out	0.44%
Short % of Float	0.56%
Short Ratio (days to cover)	3.33

Income Statement

In the last 12 months, VolitionRx had revenue of $976,516 and -$32.42 million in losses. Loss per share was -$0.40.

Revenue	976,516
Gross Profit	976,516
Operating Income	-32.77M
Pretax Income	-34.91M
Net Income	-32.42M
EBITDA	-31.64M
EBIT	-32.77M
Loss Per Share	-$0.40

Full Income Statement

Balance Sheet

The company has $6.00 million in cash and $5.86 million in debt, giving a net cash position of $137,875 or $0.00 per share.

Cash & Cash Equivalents	6.00M
Total Debt	5.86M
Net Cash	137,875
Net Cash Per Share	$0.00
Equity (Book Value)	-22.90M
Book Value Per Share	-0.26
Working Capital	-23.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.05 million and capital expenditures -$649,924, giving a free cash flow of -$17.69 million.

Operating Cash Flow	-17.05M
Capital Expenditures	-649,924
Free Cash Flow	-17.69M
FCF Per Share	-$0.19

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-3,355.66%
Pretax Margin	-3,357.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,330.23%

Dividends & Yields

VolitionRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.74%
Shareholder Yield	-33.74%
Earnings Yield	-58.67%
FCF Yield	-32.02%

Analyst Forecast

The average price target for VolitionRx is $4.17, which is 595.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.17
Price Target Difference	595.00%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	157.44%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VolitionRx has an Altman Z-Score of -32.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-32.5
Piotroski F-Score	2